Managing congestive heart failure patient factors in the device era.
Device-based care such as implantable cardioverter-defibrillators and cardiac resynchronization therapy extends congestive heart failure (CHF) care into a new era. The purpose of this paper is 2-fold: (1) to review the development of device-based CHF management and the implications from a medical and patient management perspective, and (2) to provide assessment and treatment approaches on how to clinically manage patient outcomes optimally. Quality of life, depression, and anxiety are targeted as concerns for patients with CHF and cardiac resynchronization therapy/implantable cardioverter-defibrillators. Brief clinic-based interview questions and formal assessment tools are reviewed. Furthermore, a cognitive-behavioral paradigm using the "Appropriate Education, Behavioral Support, and Cognitive Coping" (ABC) model is proposed to aid health care professionals in addressing patients' device-specific concerns. Available research suggests the need for future studies assessing the efficacy of cognitive-behavioral treatments in patients with CHF and cardiac resynchronization therapy/implantable cardioverter-defibrillators.
Sears
Samuel F
SF
College of Public Health and Health Professions, Department of Clinical & Health Psychology, University of Florida Health Science Center, Gainesville, FL 32610, USA. ssears@phhp.ufl.edu
Stutts
Lauren A
LA
Aranda
Juan M
JM
Handberg
Eileen M
EM
Conti
Jamie B
JB
D001007:Anxiety / Q000453:epidemiology; D017147:Defibrillators, Implantable; D003863:Depression / Q000453:epidemiology; D006333:Heart Failure / Q000150:complications / Q000523:psychology / Q000628:therapy*; D006801:Humans; D010138:Pacemaker, Artificial; D010353:Patient Education as Topic; D011788:Quality of Life; D013315:Stress, Psychological / Q000453:epidemiology; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000209:etiology